347.94
price down icon1.51%   -5.34
after-market Dopo l'orario di chiusura: 347.78 -0.16 -0.05%
loading

Amgen Inc Borsa (AMGN) Ultime notizie

pulisher
Apr 05, 2026

Amgen Inc. Shs Unsponsored Brazilian Depository Receipt Repr 0.03571 Sh Trade Ideas — BMFBOVESPA:AMGN34 - TradingView

Apr 05, 2026
pulisher
Apr 05, 2026

Amgen Inc. $AMGN Position Boosted by JB Capital LLC - MarketBeat

Apr 05, 2026
pulisher
Apr 05, 2026

A Look At Amgen (AMGN) Valuation After New Repatha Data And Zai Lab Oncology Collaboration - simplywall.st

Apr 05, 2026
pulisher
Apr 04, 2026

Amgen Inc. (AMGN) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026
pulisher
Apr 04, 2026

Zai Lab Limited And Amgen Inc. Collaborate To Advance DLL3 Targeted Combination Therapy In Small Cell Lung Cancer - BioPharma APAC

Apr 04, 2026
pulisher
Apr 04, 2026

Thurston Springer Miller Herd & Titak Inc. Acquires 3,354 Shares of Amgen Inc. $AMGN - MarketBeat

Apr 04, 2026
pulisher
Apr 04, 2026

SteelPeak Wealth LLC Has $37.88 Million Holdings in Amgen Inc. $AMGN - MarketBeat

Apr 04, 2026
pulisher
Apr 03, 2026

AbbVie & Amgen: Safe Dividend Stocks for Recession Fears | 2026News and Statistics - IndexBox

Apr 03, 2026
pulisher
Apr 03, 2026

Amgen Beats Estimates by $400 Million in Q4: Here’s Why Analysts Target $350 - TIKR.com

Apr 03, 2026
pulisher
Apr 03, 2026

Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study - TipRanks

Apr 03, 2026
pulisher
Apr 03, 2026

Dorato Capital Management Invests $1.58 Million in Amgen Inc. $AMGN - MarketBeat

Apr 03, 2026
pulisher
Apr 03, 2026

Aberdeen Group plc Acquires 27,107 Shares of Amgen Inc. $AMGN - MarketBeat

Apr 03, 2026
pulisher
Apr 02, 2026

How Tavneos Safety Risks and New Oncology Pact Could Rebalance Amgen’s (AMGN) Risk‑Reward Profile - Yahoo Finance

Apr 02, 2026
pulisher
Apr 02, 2026

Amgen (AMGN) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance Australia

Apr 02, 2026
pulisher
Apr 02, 2026

Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters

Apr 02, 2026
pulisher
Apr 02, 2026

2 Healthcare Dividend Stocks to Buy as the Tech-Heavy Nasdaq Dips Below Correction Territory - The Motley Fool

Apr 02, 2026
pulisher
Apr 02, 2026

Amgen's Diversification Continues To Pay Off, RBC Says - Moomoo

Apr 02, 2026
pulisher
Apr 02, 2026

Turning Up the Volume on IgG4-RD Awareness and Diagnosis - Amgen

Apr 02, 2026
pulisher
Apr 02, 2026

Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next - tipranks.com

Apr 02, 2026
pulisher
Apr 02, 2026

Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now? - Insider Monkey

Apr 02, 2026
pulisher
Apr 02, 2026

Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $390 - Moomoo

Apr 02, 2026
pulisher
Apr 02, 2026

HF Advisory Group LLC Buys 7,548 Shares of Amgen Inc. $AMGN - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 - GlobeNewswire

Apr 02, 2026
pulisher
Apr 02, 2026

Pediatric Neuroblastoma Treatment Market Outlook 2026-2030 & 2035United Therapeutics Corporation, APEIRON Biologics, Pfizer, Bayer, and Amgen Dominate - Yahoo Finance

Apr 02, 2026
pulisher
Apr 02, 2026

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: ReportAmgen (NASDAQ:AM - Benzinga

Apr 02, 2026
pulisher
Apr 02, 2026

Zai Lab (09688.HK) Enters Global Collaboration with Amgen (AMGN.US) to Explore Novel ADC and BiTE Combination Therapy - AASTOCKS.com

Apr 02, 2026
pulisher
Apr 02, 2026

AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Will FDA Tavneos Safety Scrutiny and New Lung Cancer Combo Trial Change Amgen's (AMGN) Narrative? - simplywall.st

Apr 01, 2026
pulisher
Apr 01, 2026

AMGEN INC (AMGNCL.SN) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen Inc. Stock: Biotech Leader's Strategic Pipeline and Oncology Focus Drive Long-Term Investor Va - AD HOC NEWS

Apr 01, 2026
pulisher
Apr 01, 2026

Zai Lab gains after Amgen clinical trial deal (ZLAB:NASDAQ) - Seeking Alpha

Apr 01, 2026
pulisher
Apr 01, 2026

Here's What You Need to Know about Amgen, Inc's AMG-145 - Yahoo

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen (AMGN) and Zai Lab Partner for Lung Cancer Treatment Study - gurufocus.com

Apr 01, 2026
pulisher
Apr 01, 2026

Once the center of a $3.7 billion buyout, drug blamed for eight deaths draws FDA alert - The Business Journals

Apr 01, 2026
pulisher
Apr 01, 2026

Zai Lab Limited and Amgen Inc Enter Global Clinical Trial Collaboration Agreement - MarketScreener

Apr 01, 2026
pulisher
Apr 01, 2026

Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $432 - Moomoo

Apr 01, 2026
pulisher
Apr 01, 2026

A two-drug small cell lung cancer trial pairs Amgen with Zai Lab - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Highline Wealth Partners LLC Sells 4,004 Shares of Amgen Inc. $AMGN - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Nisa Investment Advisors LLC Has $55.22 Million Stake in Amgen Inc. $AMGN - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen Inc. $AMGN Shares Sold by Meyer Handelman Co. - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen Inc. $AMGN Shares Bought by Moody Lynn & Lieberson LLC - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen Inc. (0R0T.IL) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada

Apr 01, 2026
pulisher
Apr 01, 2026

Sarcopenia Treatments Market Is Going to Boom | AbbVie • Amgen • Pfizer • Novartis - openpr.com

Apr 01, 2026
pulisher
Apr 01, 2026

BTC Capital Management Inc. Sells 4,196 Shares of Amgen Inc. $AMGN - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

Amgen Inc. (NASDAQ:AMGN) Given Average Rating of "Hold" by Analysts - MarketBeat

Apr 01, 2026
pulisher
Mar 31, 2026

FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths - wsj.com

Mar 31, 2026
pulisher
Mar 31, 2026

US FDA warns of liver injury cases tied to Amgen's rare disease drug - Reuters

Mar 31, 2026
pulisher
Mar 31, 2026

FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos UseAmgen (NASDAQ:AMGN) - Benzinga

Mar 31, 2026
pulisher
Mar 31, 2026

FDA Flags Serious Liver Risks with Amgen's Tavneos (AMGN) - GuruFocus

Mar 31, 2026
pulisher
Mar 31, 2026

FDA issues warning for Amgen's Tavneos following serious liver injury cases - Seeking Alpha

Mar 31, 2026
pulisher
Mar 31, 2026

Amgen CEO Bob Bradway's 2025 Letter to Shareholders - Amgen

Mar 31, 2026
pulisher
Mar 31, 2026

Amgen’s Tavneos Associated With Liver Injury, Deaths, FDA Says - Bloomberg.com

Mar 31, 2026
pulisher
Mar 31, 2026

Amgen price breaches upside trend lineForecast tody31-03-2026 - Economies.com

Mar 31, 2026
pulisher
Mar 31, 2026

Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

The Zacks Analyst Blog Roche Holding, AT&T and Amgen - The Globe and Mail

Mar 31, 2026
pulisher
Mar 31, 2026

Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 31, 2026
pulisher
Mar 30, 2026

Top Stock Reports for Roche, AT&T & Amgen - The Globe and Mail

Mar 30, 2026
pulisher
Mar 30, 2026

Jefferies reiterates Amgen stock Hold rating on TED trial data - Investing.com

Mar 30, 2026
$139.71
price down icon 0.42%
NVO NVO
$36.98
price up icon 1.37%
PFE PFE
$28.32
price down icon 0.81%
NVS NVS
$154.03
price down icon 0.68%
MRK MRK
$120.87
price up icon 0.02%
Capitalizzazione:     |  Volume (24 ore):